Durso Jerome Benedict's Form 4 filing
Altimmune, Inc. (ALT) · filed Dec 22, 2025
- Accession no.
- 0001698665-25-000005
- Filed
- Dec 22, 2025
- Trade date
- Dec 22, 2025
- Filing delay
- Same day
- Rule 10b5-1 plan
- Not checked
This filing lists 1 non-derivative transaction and 0 derivative transactions. Open-market purchases total $51.6K. It was filed on the trade date.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Durso Jerome BenedictCIK 0001698665 | Director |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Dec 22, 2025 | Common Stock, par value $0.0001 | PPurchaseAcquired | +12,500 | $4.13 | +$51,625 | 12,500 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.